Replies to post #7443 on Eco Science Solutions Inc. (fka ESSI)

[JustStartingOut]

Invest right.... I agree 100%... When I saw one of the PRs about "looking" for someone or some company to back the trials, that's when I sold.

I am a novice investor in stocks, but really thought since this drug had already been approved, and was just testing a new use for it, it would have been a slam dunk...

I have such a small investment here that it won't make me rich, and given that I am a 44 year old female, I'll be hitting menopause soon... I was really looking forward to having something proven to help with the hot flashes... And make a few bucks in the meantime!

-Michele

[Rocco!!]

Good morning - you're correct, this is also written on the 10-K posted on May of this year. As far as I know the plan is still going as scheduled. See below and look for the end of the 3rd qtr. to see a PR or something from ESSI.


"The Company has recently completed its Clinical Trial Protocol entitled “An Open Label Escalating Study to Determine Maximum Necessary Dose (MND) of Homatropine Methylbromide needed for Palliation of Hot Flashes in Menopausal Women,” dated March 14, 2013, a copy of which is attached herewith as Exhibit 99.6, for its new drug indication, with the goal of generating data that supports its claims. The Company has retained a team of medical professionals and is ready to begin Phase I of the Clinical Trial/Study (the “Study”).

On May 14, 2013, the Company entered into a Clinical Trial/Study Agreement with the American Institute of Research (the “CTS Agreement”) to, among other things, conduct the Study. A copy of the CTS Agreement is included in this filing as Exhibit 10.13. The Company’s goal is to complete the Study, barring any unforeseen delays, by the end of the 3 nd calendar quarter of 2013."